| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |